Patient P-02650

Synthetic patientMETA-24 · Day 171 · 35–44 · F · baseline S02Steering view · 3D Open companion preview

Therapy response

Favorable

Tolerance

Favorable

GI state

Favorable

Inflammatory state

Favorable

Nutritional resilience

Declining

Discontinuation risk

11%

Trajectory

Baseline → today → 30-day prediction · hover a day for signals and events

solid = observed · dashed = predicted

Day 0 META-24 started — Baseline state S02
Day 28 HY-01 recommended — Hydration Protocol HY-01
Day 29 Patient accepted — Started HY-01 in the companion
Day 33 No meaningful change — Hydration Protocol HY-01

What changed?

Trajectory is tracking the baseline prediction.

Primary contributors, last 14 days

Nutritional resilience-5
Treatment adherence+4
GI instability-3
Toxicity-3
Inflammatory activity-2

What helped?

Hydration Protocol HY-01Day 28
Result: no meaningful change

LIFE OS recommendation

No intervention is indicated right now. The trajectory is stable relative to similar patients. See what worked for similar patients.

Daily trackers

Molecule settings

The trackers this program marks as important, last 14 days vs the 14 before.

Active minutes

Wearable

74 min

worsening · -3.2 vs previous 14 d

Sleep duration

Wearable

6.5 h

stable · +0.0 vs previous 14 d

Energy level

Daily log

6.9/10

worsening · -0.3 vs previous 14 d

Steps

Wearable

7,681

worsening · -355 vs previous 14 d

GI burden

Companion

16.5/100

worsening · +4.9 vs previous 14 d

Adherence

Companion

95.3 %

improving · +3.6 vs previous 14 d

Sleep quality

Wearable

37.1/100

worsening · -3.0 vs previous 14 d

Glucose, CGM daily mean

CGM

121 mg/dL

stable · -0.5 vs previous 14 d

This trajectory is doing well — what to keep, what to watch

Steering view →

Heading towards restoration · 90 from the failing basin, 6 from restoration.

Good elements to keep

Butyrate producers intact
hidden · steering +7.5
Protein (supports)
perturbation · steering +5.6
Hydration Protocol HY-01
intervention · steering +1.5
Protein
supporter · GI -3 next day

Main detractors to watch

Bacteroides fragilis elevated
hidden · steering -7.4
IL6 high-expression variant
hidden · steering -7.3
Poor-sleep week
perturbation · steering -3

State influencers · digestive

Next-day GI change on high-intake vs low-intake days, last 60 days. Attribution from this patient's own log; sensitivity set by their biology.

Protein
-3supporter · 95%
Ultra-processed food
+1.1no signal · 34%
Histamine load
+0.9no signal · 34%
Simple carbohydrates
+0.7no signal · 28%
Insoluble fibre
-0.7no signal · 20%
Caffeine
-0.5no signal · 19%
Alcohol
+0.5no signal · 16%
Dietary fat load
+0.1no signal · 15%

Biological layers

Which pathways look influenced, and by which layer of this person's biology.

Pathways under pressure

Inflammatory signalling ↓45
- DNAIL6 -174 variant raises baseline inflammatory tone
- MicrobiomeBacteroides fragilis expansion

DNA

Fictional pharmacogenomic panel

IL6 -174 G/C
Higher inflammatory tone
CYP2D6 Normal metabolizer
Expected exposure

Microbiome

Shannon diversity 3.1 · butyrate capacity 79/100

Akkermansia muciniphilaNormal
Faecalibacterium prausnitziiNormal
Bacteroides fragilisHigh
Bifidobacterium longumNormal
EnterobacteriaceaeNormal

Wearable, last 14 days

daily evolution fed into the runtime

HRV: 47 ms
Sleep: 6.1 h
Steps: 7,463
Resting HR: 69 bpm

Daily log: GI score 17, nutritional resilience 62, adherence 95.

What this patient sees in NostraAI

The content that steers the trajectory: what to eat, what to do, what to take.

Open companion preview

What to eat

Keep meals regular; three to four moderate portions spaced through the day
Include a cooked vegetable portion with each main meal
Keep fibre steady; no new sources this week
Eat slowly and stop at comfortable fullness — smaller volume, more often

What to do

Log the daily check-in; one line is enough
Keep the current walking rhythm
Keep the sleep window steady
Keep hydration steady: small amounts through the day rather than large volumes at once

What to take

Take the dose at the same time relative to your evening meal
No additional supplements this week
Fictional demo item: continue vitamin D as before

284 biologically similar trajectories

Black: this patient. Green: similar patients whose intervention worked. Orange: similar patients where it did not.

Patient	Similarity	Baseline	Intervention	Outcome	Response today
P-02667	51%	S08	HY-01	improved	77
P-02415	50%	S17	GI-04	improved	86
P-02450	48%	S12	NP-02	improved	92
P-02690	47%	S02	ME-01	improved	73
P-02630	45%	S17	NP-02	improved	76
P-02486	44%	S10	ME-01	improved	86
P-02277	43%	S05	AD-05	improved	92
P-02193	42%	S11	CR-01	improved	87
P-02068	38%	S14	NP-02	improved	83
P-02127	38%	S11	SC-12	improved	73
P-02249	37%	S09	DT-01	improved	100
P-02464	37%	S18	ME-01	improved	68